CONTEXTLOGIC INC - A (LOGC) Stock News
NASDAQ:LOGC - Nasdaq - US21077C3051 - Common Stock
LOGC Latest News and Analysis
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
OAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its...
Oversold Conditions For ContextLogic (LOGC)
LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ContextLogic (NASDAQ:LOGC) just reported results for the second quarter of 2024...
ContextLogic Inc. Reports Second-Quarter Financial Results
ContextLogic Inc. Reports Second-Quarter Financial Results
OAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its...
ContextLogic Becomes Oversold (LOGC)
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
- Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated...
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a clinical-stage genetic medicine company, today reported financial results for the third quarter...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAWW, LOGC, RFP, PBFX, RNWK
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds LOGC, POSH, AERC, and BTRS Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOTZ, LOGC, OIIM, JVA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, POSH, SSNT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Investigates LogicBio Therapeutics, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of LogicBio Therapeutics,...
Looking Into LogicBio Therapeutics's Recent Short Interest
LogicBio Therapeutics's (NASDAQ:LOGC) short percent of float has fallen 62.5% since its last report. The company recently reported that it has 29 thousand shares sold short, which is 0.12% of all regular shares that are available for trading.
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!
Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale
Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale.
Shareholder Alert: Ademi LLP investigates whether LogicBio® Therapeutics, Inc. has obtained a Fair Price in its transaction with AstraZeneca
/PRNewswire/ -- Ademi LLP is investigating LogicBio (NASDAQ: LOGC) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Why Is LogicBio (LOGC) Stock Up 600% Today?
LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.
